Sanofi SA- Strategy and SWOT Report

MarketLine, July 2011, Pages: 72

Sanofi SA - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Features:

- Detailed information on Sanofi SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi SA in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi SA including a breakdown and examination of key business segments
- Intelligence on Sanofi SA’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Sanofi, formerly Sanofi-Aventis, is an international pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. It offers biopharmaceuticals, human vaccines and animal and consumer health products. Sanofi is the world's fourth largest pharmaceutical group and Europe's second largest pharmaceutical player. The group operates in more than 100 countries. It is headquartered in Paris, France, and employed 101,575 people as of December 31, 2010. Sanofi completed the acquisition of Genzyme, a US-based biotech major, for $20.1 billion in April 2011. The group recorded revenues* of E32,035 million ($42,500.8 million**) during the financial year (FY) ended December 2010, an increase of 4.2% over FY2009. The operating profit of the group was E5,961 million ($7,908.5 million**) during FY2010, a decrease of 6.4% over FY2009. The net profit was E5,467 million ($7,253.1 million**) in FY2010, an increase of 3.8% over FY2009. * Total revenues = net sales + other revenues. ** Calculated using the constant conversion rate of E1 = $1.3267 for the financial year ended December 31, 2010.

Reasons to Purchase:

- Gain understanding of Sanofi SA and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Sanofi SA as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Sanofi SA’s business structure, strategy and prospects

Company Snapshot
Sanofi SA: Company Overview
Sanofi SA: Overview and Key Facts
Sanofi SA: Overview
Sanofi SA: Key Facts
Sanofi SA: Key Employees
Sanofi SA: Key Employee Biographies
Sanofi SA: Major Products and Services
Sanofi SA: Company History
Sanofi SA: Management Statement
Sanofi SA: Locations and Subsidiaries
Sanofi SA: Key Competitors Sanofi SA: Company Analysis
Sanofi SA: Business Description
Sanofi SA: SWOT Analysis
Sanofi SA: SWOT Overview
Sanofi SA: Strengths
Sanofi SA: Weaknesses
Sanofi SA: Opportunities
Sanofi SA: Threats
Sanofi SA: Corporate Financial Deals Activity
Sanofi SA: Financial Deals Overview
Sanofi SA: Targets and Partners
Sanofi SA: Top Deals 2007 -YTD-2012
Sanofi SA: Advisors
Sanofi SA: Top Legal Advisors
Sanofi SA: Top Financial Advisors
Sanofi SA: Mergers and Acquisitions
Sanofi SA: Corporate Venturing
Sanofi SA: Partnership
Sanofi SA: Divestments Sanofi SA: Recent Developments
Sanofi SA: News and Events Summary
Sanofi SA: Contracts
Sanofi SA: Corporate Governance
Sanofi SA: Financial Deals
Sanofi SA: Regulatory and Legal Events
Sanofi SA: Research & Development
Sanofi SA: Strategy and Operations Appendix
Contact Us
Methodology
Definitions
About Datamonitor List of Tables Table 1: Sanofi SA: Key Facts Table 2: Sanofi SA: Key Employees Table 4: Sanofi SA: Key Competitors Table 5: Sanofi SA: Deal Activity by Deal Type - Volume (TTM-) Table 6: Sanofi SA: M&A Activity by Geography (TTM-) Table 7: Sanofi SA: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Table 8: Sanofi SA: M&A Average Deal Size - Value (US$m) Table 9: Sanofi SA: Targets and Partners Table 10: Sanofi SA: Top Deals 2007 -YTD-2012 Table 11: Sanofi SA: Legal Advisor Ranking by Value (US$m) Table 12: Sanofi SA: Financial Advisor Ranking by Value (US$m) Table 13: Sanofi SA: M&A Volume and Value Trend (2008 - YTD-2012) Table 14: Sanofi SA: M&A Activity by Geography (2008 - YTD-2012) Table 15: Sanofi SA: Corporate Venturing Volume and Value Trend (2008 - YTD-2012) Table 16: Sanofi SA: Corporate Venturing by Geography (2008 - YTD-2012) Table 17: Sanofi SA: Partnership Volume and Value Trend (2008 - YTD-2012) Table 18: Sanofi SA: Partnership Trend by Deal Type (2008 - YTD-2012) Table 19: Sanofi SA: Divestments Volume and Value Trend (2008 - YTD-2012) Table 20: Sanofi SA: Divestments by Geography (2008 - YTD-2012) Table 21: Sanofi SA: News and Events Summary Table 22: Sanofi SA: Contracts Table 23: Sanofi SA: Corporate Governance Table 24: Sanofi SA: Financial Deals Table 25: Sanofi SA: Regulatory and Legal Events Table 26: Sanofi SA: Research & Development Table 27: Sanofi SA: Strategy and Operations List of Figures Figure 1: Sanofi SA: Deal Activity by Deal Type - Volume (TTM-) Figure 2: Sanofi SA: M&A Activity by Geography (TTM-) Figure 3: Sanofi SA: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Figure 4: Sanofi SA: M&A Average Deal Size - Value (US$m) Figure 5: Sanofi SA: M&A Volume and Value Trend (2008 - YTD-2012) Figure 6: Sanofi SA: M&A Activity by Geography (2008 - YTD-2012) Figure 7: Sanofi SA: Corporate Venturing Volume and Value Trend (2008 - YTD-2012) Figure 8: Sanofi SA: Corporate Venturing by Geography (2008 - YTD-2012) Figure 9: Sanofi SA: Partnership Volume and Value Trend (2008 - YTD-2012) Figure 10: Sanofi SA: Partnership Trend by Deal Type (2008 - YTD-2012) Figure 11: Sanofi SA: Divestments Volume and Value Trend (2008 - YTD-2012) Figure 12: Sanofi SA: Divestments by Geography (2008 - YTD-2012)

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Charter Schools - Global Outlook
• Sports and Fitness Nutrition - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Defense Robotics - Global Strategic Business Report
• The Global UAV Payload Market 2012-2022
• Private Tutoring - Global Strategic Business Report